A Big Conference a Week After the Public FDA Warning Letters

By /

Receive a Regenexx® Patient Info Packet by email and learn why it's a superior regenerative solution.

Last week the FDA released multiple warning letters and public announcements that made it crystal clear that companies selling exosome and umbilical cord “stem cell” products were violating the law. This week I was asked to lecture in a regenerative medicine section of the A4M conference in Las Vegas. Hence, I took a stroll through the exhibitor space to see who had modified their messaging to come into compliance. The results blew me away.

Prior FDA Letters to Birth Tissue Vendors

The FDA to date has issued many warning and other letters to various birth tissue manufacturers. These all generally say that they are not permitted to call these stem cell products using a basic donor tissue registration. These have included letters to:

To explain further, the issue with these companies from an FDA standpoint is what they claim to be selling. Remember that the FDA is a system whereby what you claim to sell drives the regulatory paradigm. For example, charcoal, when sold for water purification, doesn’t need FDA approval, but when it’s sold to treat poisoning, it does need FDA approval. Hence, as we and others have shown, while none of these companies actually sell products that contain live and viable stem cells, just their claim to sell stem cells requires that they get full FDA approval and not a simple tissue registration.

The Recent FDA Warning

While anyone reading the above letters would be very clear that they are not permitted to sell a birth tissue product and claim that it has stem cells, believe it or not, few seemed to get the memo. Hence, the FDA did something they rarely do this past week-they went big and bold by issuing two different public warnings. One was about Liveyon and two other manufacturers of umbilical cord tissue that were claiming to sell stem cell products. The other was a shot across the bow to companies claiming to sell exosome products. Both letters made it very clear to all of these companies that you had better have a full FDA drug approval in place if you claim to sell either umbilical cord derived stem cells or exosomes. They also made it clear that NONE of these companies making these claims has FDA approval.

My A4M Experience

Given that the above warning letters were a really big deal, I expected these to put a lid on anyone who was claiming to sell umbilical cord stem cells or exosomes. Hence, while I had been asked to give a lecture at the annual A4M conference in Las Vegas on orthopedic regenerative medicine on our randomized controlled trials, I was blown away that very few physicians understood the significance of these letters. For example, when I asked a lecturer on exosomes about the FDA warning that he failed to mention during his lecture, it seemed like I was bringing up the fact that the dog had just farted. Nobody seemed to want to talk frankly about it. That didn’t stop me from giving a barn burner of a lecture when I was on the podium. I very clearly told the room full of physicians all about the fact that anybody in the exhibition hall that claimed to be selling stem cells or exosomes was, in my opinion, violating federal law.

The Liveyon Response

Interestingly, Liveyon announced on Friday that it would cease sales of its product, pending a future FDA drug approval. I’m not sure that there could be any move that more clearly demonstrates that the FDA means business here. So how did the companies exhibiting their products at the massive A4M conference react?

The A4M Exhibitor Space

First, the exhibitor hall for this huge conference is massive. It took the better part of an hour to walk the whole thing. I counted 7 companies that were selling either umbilical cord tissue or exosomes (pictures above). These were:

  • Predictive Biotech-Wharton’s Jelly
  • Kimera-Exosomes
  • Organicell-Exosomes
  • Invitrx-Umbilical cord “stem cells”
  • Regenerative Labs-Wharton’s Jelly “stem cells”
  • XO Stem-Exosomes
  • Direct Biologics-Exosomes

I have Predictive Biotech listed first, as I have covered them many times on the blog and I was surprised to see that their booth didn’t use the term “stem cells”. They have never been shy about advertising that one of their products, “CoreCyte” is a stem cell product, so I checked their website. Have they changed their ways online? Nope. A check of their website on 12/13 demonstrated the same table that’s been there for a while now still claims that CoreCyte is a viable stem cell product.

Kimera has been the biggest exosome player in the market, so it’s not surprising that their booth had the term “exosomes” plastered all over it. Their website also states that they still sell exosomes. So in my opinion, Kimera is still violating FDA regulations.

Here’s a summary of all of the companies and what I found:

As you can see, the other companies including Organicell, Invitrx, XOStem, Direct Biologics, and Regenerative Labs, in my opinion, were all not FDA compliant either in their exhibitor booth or on their websites. So that’s 100% non-compliance even after a very big FDA public warning.

What Will Happen Next?

Is there a way that the FDA can get these companies to comply? That seems to be the billion-dollar question. More warning letters? More public warnings? Criminal charges? Your guess is as good as mine.

The upshot? A week after the FDA fired a serious shot across the bow of the birth tissue and exosome industry, these companies are still selling unapproved drug products. Will these companies stop selling these products or will it take enhanced FDA enforcement? Only time will tell.

Category: Uncategorized

Leave a Reply

Your email address will not be published. Required fields are marked *

1 thought on “A Big Conference a Week After the Public FDA Warning Letters

  1. DavefromLA

    With no enforcement, there’s no law. But great detective work Dr. Centeno. I hope someone from the FDA is reading your blog.

Chris Centeno, MD

Regenexx Founder

Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications.
View Profile

Get Blog Updates by Email

Get fresh updates and insights from Regenexx delivered straight to your inbox.

Find a Regenexx Provider

Regenexx is a world-wide network of specially trained physicians providing the world's most advanced, research-driven, regenerative-medicine treatments in North America, Europe, the Middle East, Asia and Australia.

Regenerative procedures are commonly used to treat musculoskelatal trauma, overuse injuries, and degenerative issues, including failed surgeries.
Select Your Problem Area
Shoulder

Shoulder

Many Shoulder and Rotator Cuff injuries are good candidates for regenerative treatments. Before considering shoulder arthroscopy or shoulder replacement, consider an evaluation of your condition with a regenerative treatment specialist.

  • Rotator Cuff Tears and Tendinitis
  • Shoulder Instability
  • SLAP Tear / Labral Tears
  • Shoulder Arthritis
  • Other Degenerative Conditions & Overuse Injuries
Learn More
Cervical Spine

Spine

Many spine injuries and degenerative conditions are good candidates for regenerative treatments and there are a number of studies showing promising results in treating a wide range of spine problems. Spine surgery should be a last resort for anyone, due to the cascade of negative effects it can have on the areas surrounding the surgery. And epidural steroid injections are problematic due to their long-term negative impact on bone density.

  • Herniated, Bulging, Protruding Discs
  • Degenerative Disc Disease
  • SI Joint Syndrome
  • Sciatica
  • Pinched Nerves and General Back Pain
  • And more
Learn More
Knee

Knees

Knees are the target of many common sports injuries. Sadly, they are also the target of a number of surgeries that research has frequently shown to be ineffective or minimally effective. Knee arthritis can also be a common cause for aging athletes to abandon the sports and activities they love. Regenerative procedures can be used to treat a wide range of knee injuries and conditions. They can even be used to reduce pain and delay knee replacement for more severe arthritis.

  • Knee Meniscus Tears
  • Knee ACL Tears
  • Knee Instability
  • Knee Osteoarthritis
  • Other Knee Ligaments / Tendons & Overuse Injuries
  • And more
Learn More
Lower Spine

Spine

Many spine injuries and degenerative conditions are good candidates for regenerative treatments and there are a number of studies showing promising results in treating a wide range of spine problems. Spine surgery should be a last resort for anyone, due to the cascade of negative effects it can have on the areas surrounding the surgery. And epidural steroid injections are problematic due to their long-term negative impact on bone density.

  • Herniated, Bulging, Protruding Discs
  • Degenerative Disc Disease
  • SI Joint Syndrome
  • Sciatica
  • Pinched Nerves and General Back Pain
  • And more
Learn More
Hand & Wrist

Hand & Wrist

Hand and wrist injuries and arthritis, carpal tunnel syndrome, and conditions relating to overuse of the thumb, are good candidates for regenerative treatments. Before considering surgery, consider an evaluation of your condition with a regenerative treatment specialist.
  • Hand and Wrist Arthritis
  • Carpal Tunnel Syndrome
  • Trigger Finger
  • Thumb Arthritis (Basal Joint, CMC, Gamer’s Thumb, Texting Thumb)
  • Other conditions that cause pain
Learn More
Elbow

Elbow

Most injuries of the elbow’s tendons and ligaments, as well as arthritis, can be treated non-surgically with regenerative procedures.

  • Golfer’s elbow & Tennis elbow
  • Arthritis
  • Ulnar collateral ligament wear (common in baseball pitchers)
  • And more
Learn More
Hip

Hip

Hip injuries and degenerative conditions become more common with age. Do to the nature of the joint, it’s not quite as easy to injure as a knee, but it can take a beating and pain often develops over time. Whether a hip condition is acute or degenerative, regenerative procedures can help reduce pain and may help heal injured tissue, without the complications of invasive surgical hip procedures.

  • Labral Tear
  • Hip Arthritis
  • Hip Bursitis
  • Hip Sprain, Tendonitis or Inflammation
  • Hip Instability
Learn More
Foot & Ankle

Foot & Ankle

Foot and ankle injuries are common in athletes. These injuries can often benefit from non-surgical regenerative treatments. Before considering surgery, consider an evaluation of your condition with a regenerative treatment specialist.
  • Ankle Arthritis
  • Plantar fasciitis
  • Ligament sprains or tears
  • Other conditions that cause pain
Learn More

Is Regenexx Right For You?

Request a free Regenexx Info Packet

REGENEXX WEBINARS

Learn about the #1 Stem Cell & Platelet Procedures for treating arthritis, common joint injuries & spine pain.

Join a Webinar

RECEIVE BLOG ARTICLES BY EMAIL

Get fresh updates and insights from Regenexx delivered straight to your inbox.

Subscribe to the Blog

FOLLOW US

Copyright © Regenexx 2020. All rights reserved. | Privacy Policy

*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.

LinkedIn
Email